Mahindra will raise prices across most SUVs and CVs from April 6, 2026, citing rising costs, while the XUV 7XO remains ...
“Mahindra & Mahindra, India's leading SUV manufacturer, today announced an increase in prices of up to 2.5% for its ICE SUV ...
Mahindra & Mahindra has announced a price hike of up to 2.5 per cent on its non-electric SUVs and commercial vehicles ...
As is typically seen, Mahindra’s price increase at the start of the new financial year is being linked to rising production ...
MedPage Today on MSN
PCSK9 Drug Prevents First Heart Events in Diabetes Patients Without Atherosclerosis
VESALIUS-CV further extends PCSK9 inhibitor's primary prevention benefits ...
In high-risk patients with diabetes but without known atherosclerosis, evolocumab reduced risk for a first major CV event compared with placebo, according to a subgroup analysis of the VESALIUS-CV ...
JOHNSTOWN — Katie Ross struck out six and threw a five-inning no-hitter and had two hits, including a double, with two RBIs ...
India’s automobile sector is expected to see a moderation in growth in FY2027 after a strong, policy-driven expansion in ...
Investigators suggest LDL targets typically reserved for secondary prevention are best in high-risk patients with diabetes.
A review identifies 12 common hypertension errors, highlighting missed diagnostic steps and treatment gaps that may affect ...
The EEOC is suing Butterball, alleging the company fired a long-tenured employee undergoing cancer treatment rather than ...
A subgroup analysis of the VASALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results